123I-ADAM SPECT imaging of serotonin transporter binding in patients with night eating syndrome: a preliminary report.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 2441922)

Published in Psychiatry Res on February 20, 2008

Authors

Jennifer D Lundgren1, Andrew B Newberg, Kelly C Allison, Nancy A Wintering, Karl Ploessl, Albert J Stunkard

Author Affiliations

1: Center for Weight and Eating Disorders, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Articles cited by this

The night-eating syndrome; a pattern of food intake among certain obese patients. Am J Med (1955) 2.22

Circadian eating and sleeping patterns in the night eating syndrome. Obes Res (2004) 2.15

Binge eating disorder and night eating syndrome: a comparative study of disordered eating. J Consult Clin Psychol (2005) 2.03

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry (1998) 2.03

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry (2003) 1.93

Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res (2003) 1.58

The Night Eating Questionnaire (NEQ): psychometric properties of a measure of severity of the Night Eating Syndrome. Eat Behav (2007) 1.56

Prevalence of the night eating syndrome in a psychiatric population. Am J Psychiatry (2006) 1.20

A randomized, placebo-controlled trial of sertraline in the treatment of night eating syndrome. Am J Psychiatry (2006) 1.13

[123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol Psychiatry (2001) 1.05

Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder. Biol Psychiatry (2003) 1.04

123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. J Nucl Med (2005) 1.02

Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients. Am J Psychiatry (2000) 1.02

Successful treatment of nocturnal eating/drinking syndrome with selective serotonin reuptake inhibitors. Int Clin Psychopharmacol (2003) 0.99

A paradigm for facilitating pharmacotherapy at a distance: sertraline treatment of the night eating syndrome. J Clin Psychiatry (2006) 0.97

Clinical trial of sertraline in the treatment of night eating syndrome. Int J Eat Disord (2004) 0.93

Serotonin transporters upregulate with chronic cocaine use. J Chem Neuroanat (2000) 0.92

Reduced serotonin transporter binding in binge eating women. Psychopharmacology (Berl) (2001) 0.91

[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry (2000) 0.91

Comparison of anatomically-defined versus physiologically-based regional localization: effects on PET-FDG quantitation. J Nucl Med (1993) 0.88

Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT. J Nucl Med (2001) 0.88

In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram. Psychopharmacology (Berl) (2006) 0.86

Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD). Eur Arch Psychiatry Clin Neurosci (2004) 0.85

SPECT of serotonin transporters using 123I-ADAM: optimal imaging time after bolus injection and long-term test-retest in healthy volunteers. J Nucl Med (2005) 0.85

Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study. Psychopharmacology (Berl) (2006) 0.84

Brain SPECT imaging and whole-body biodistribution with [(123)I]ADAM - a serotonin transporter radiotracer in healthy human subjects. Nucl Med Biol (2006) 0.81

Elevated midbrain serotonin transporter availability in mixed mania: a case report. BMC Psychiatry (2004) 0.80

Articles by these authors

Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med (2005) 5.35

Depression and obesity. Biol Psychiatry (2003) 3.23

Overvaluation of shape and weight in binge eating disorder and overweight controls: refinement of a diagnostic construct. J Abnorm Psychol (2008) 2.46

Deep brain stimulation in the treatment of obesity. J Neurosurg (2008) 2.40

Parental feeding attitudes and styles and child body mass index: prospective analysis of a gene-environment interaction. Pediatrics (2004) 2.22

Getting worse: the stigmatization of obese children. Obes Res (2003) 2.20

Circadian eating and sleeping patterns in the night eating syndrome. Obes Res (2004) 2.15

Binge eating disorder and night eating syndrome: a comparative study of disordered eating. J Consult Clin Psychol (2005) 2.03

Stigmatized students: age, sex, and ethnicity effects in the stigmatization of obesity. Obes Res (2005) 1.73

Assessment of sleep in women with night eating syndrome. Sleep (2006) 1.56

The Night Eating Questionnaire (NEQ): psychometric properties of a measure of severity of the Night Eating Syndrome. Eat Behav (2007) 1.56

PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine. J Nucl Med (2011) 1.50

Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Alzheimers Dement (2011) 1.41

Proposed diagnostic criteria for night eating syndrome. Int J Eat Disord (2010) 1.41

Eating in the absence of hunger: a genetic marker for childhood obesity in prepubertal boys? Obesity (Silver Spring) (2006) 1.37

Pregnancy and obesity: a review and agenda for future research. J Womens Health (Larchmt) (2006) 1.37

One-year results of the Think Health! study of weight management in primary care practices. Obesity (Silver Spring) (2011) 1.37

Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. J Am Chem Soc (2010) 1.36

Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One (2012) 1.35

Binge eating disorder: disorder or marker? Int J Eat Disord (2003) 1.25

Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease. J Nucl Med (2006) 1.22

Prevalence of the night eating syndrome in a psychiatric population. Am J Psychiatry (2006) 1.20

Circadian rhythm profiles in women with night eating syndrome. J Biol Rhythms (2009) 1.19

Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors. J Nucl Med (2011) 1.15

Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. J Nucl Med (2005) 1.15

Changes in symptoms of depression with weight loss: results of a randomized trial. Obesity (Silver Spring) (2009) 1.13

A randomized, placebo-controlled trial of sertraline in the treatment of night eating syndrome. Am J Psychiatry (2006) 1.13

Neuroendocrine profiles associated with energy intake, sleep, and stress in the night eating syndrome. J Clin Endocrinol Metab (2005) 1.12

FDG-PET findings in patients with suspected encephalitis. Clin Nucl Med (2004) 1.11

The application of ecological momentary assessment to the study of night eating. Int J Eat Disord (2007) 1.10

Night eating syndrome among nonobese persons. Int J Eat Disord (2004) 1.10

Beverage consumption patterns of children born at different risk of obesity. Obesity (Silver Spring) (2008) 1.10

Night eating syndrome and binge eating disorder among persons seeking bariatric surgery: prevalence and related features. Obesity (Silver Spring) (2006) 1.10

A descriptive study of non-obese persons with night eating syndrome and a weight-matched comparison group. Eat Behav (2008) 1.09

Prevalence of night eating in obese and nonobese twins. Obesity (Silver Spring) (2009) 1.09

Binge eating disorder and night eating syndrome in adults with type 2 diabetes. Obesity (Silver Spring) (2007) 1.08

The night eating syndrome: a progress report. Appetite (2005) 1.08

Cerebral blood flow changes during retrieval of traumatic memories before and after psychotherapy: a SPECT study. Psychol Med (2007) 1.05

18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med (2002) 1.04

123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. J Nucl Med (2005) 1.02

Biphenyls labeled with technetium 99m for imaging beta-amyloid plaques in the brain. Nucl Med Biol (2005) 1.02

Facile synthesis [5-(13)C-4-(2)H(2)]-L-glutamine for hyperpolarized MRS imaging of cancer cell metabolism. Acad Radiol (2011) 1.01

Night eating syndrome : diagnosis, epidemiology and management. CNS Drugs (2005) 1.01

Appetite: measurement and manipulation misgivings. J Am Diet Assoc (2005) 1.01

Cerebral blood flow changes associated with different meditation practices and perceived depth of meditation. Psychiatry Res (2010) 1.01

A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls. Neuropsychobiology (2007) 1.00

Daily food intake in relation to dietary energy density in the free-living environment: a prospective analysis of children born at different risk of obesity. Am J Clin Nutr (2007) 0.99

A paradigm for facilitating pharmacotherapy at a distance: sertraline treatment of the night eating syndrome. J Clin Psychiatry (2006) 0.97

Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese female identical twins. Lipids (2002) 0.95

The measurement of regional cerebral blood flow during glossolalia: a preliminary SPECT study. Psychiatry Res (2006) 0.94

Greater history of weight-related stigmatizing experience is associated with greater weight loss in obesity treatment. J Health Psychol (2009) 0.94

Growth of children at high risk of obesity during the first 6 y of life: implications for prevention. Am J Clin Nutr (2005) 0.94

Maternal obesity associated with inflammation in their children. World J Pediatr (2011) 0.94

Development of criteria for a diagnosis: lessons from the night eating syndrome. Compr Psychiatry (2008) 0.94

Clinical trial of sertraline in the treatment of night eating syndrome. Int J Eat Disord (2004) 0.93

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent. Mol Pharm (2014) 0.93

Modeling circadian rhythms of food intake by means of parametric deconvolution: results from studies of the night eating syndrome. Am J Clin Nutr (2008) 0.92

High self-reported rates of neglect and emotional abuse, by persons with binge eating disorder and night eating syndrome. Behav Res Ther (2007) 0.92

Identification of an obese eating style in 4-year-old children born at high and low risk for obesity. Obesity (Silver Spring) (2009) 0.92

Dopamine transporter binding in smokers and nonsmokers. Clin Nucl Med (2007) 0.92

Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography--a novel concept. Hell J Nucl Med (2011) 0.90

Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease. Hell J Nucl Med (2012) 0.90

Dopamine transporter levels in cocaine dependent subjects. Drug Alcohol Depend (2008) 0.89

Evaluation of diagnostic criteria for night eating syndrome using item response theory analysis. Eat Behav (2008) 0.89

Positron emission tomography in seizure disorders. Ann N Y Acad Sci (2011) 0.89

Is socioeconomic status of the rearing environment causally related to obesity in the offspring? PLoS One (2011) 0.88

Adolescent eating in the absence of hunger and relation to discretionary calorie allowance. J Am Diet Assoc (2010) 0.88

Effects of an 8-week meditation program on mood and anxiety in patients with memory loss. J Altern Complement Med (2012) 0.88

Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study. Altern Ther Health Med (2012) 0.88

Night eating syndrome and binge eating disorder among persons seeking bariatric surgery: prevalence and related features. Surg Obes Relat Dis (2006) 0.87

Enantioselective radiosynthesis of positron emission tomography (PET) tracers containing [¹⁸F]fluorohydrins. J Am Chem Soc (2014) 0.86

Cognitive behavior therapy for night eating syndrome: a pilot study. Am J Psychother (2010) 0.86

Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA). J Med Chem (2011) 0.86

Psychosocial benefits of a novel mindfulness intervention versus standard support in distressed women with breast cancer. Psychooncology (2013) 0.86

Cerebral blood flow effects of yoga training: preliminary evaluation of 4 cases. J Altern Complement Med (2009) 0.84

Shared and unique genetic and environmental influences on binge eating and night eating: a Swedish twin study. Eat Behav (2009) 0.83

Double-blind, placebo-controlled, randomized pilot study of cerebral blood flow patterns employing SPECT imaging in dental postsurgical pain patients with and without pain relief. Clin Ther (2011) 0.83

Changes in cerebral blood flow and anxiety associated with an 8-week mindfulness programme in women with breast cancer. Stress Health (2012) 0.83

Behavioral management of night eating disorders. Psychol Res Behav Manag (2013) 0.83

Chemistry. Expanding the scope of fluorine tags for PET imaging. Science (2013) 0.83

PET/SPECT imaging agents for neurodegenerative diseases. Chem Soc Rev (2014) 0.82

Night eating, binge eating and related features in patients with obstructive sleep apnea syndrome. Eur Eat Disord Rev (2009) 0.82

Emotional eating moderates the relationship of night eating with binge eating and body mass. Eur Eat Disord Rev (2013) 0.82

Familial aggregation in the night eating syndrome. Int J Eat Disord (2006) 0.82

Greater striatal dopamine transporter density may be associated with major depressive episode. J Affect Disord (2012) 0.80

Visual processing impairments and decrements in regional brain activity in Alzheimer's disease. J Clin Exp Neuropsychol (2004) 0.80

Diet and nutrition in cancer survivorship and palliative care. Evid Based Complement Alternat Med (2013) 0.80

In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease. Nucl Med Biol (2010) 0.79

Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease. Eur J Nucl Med Mol Imaging (2004) 0.79

The treatment of night eating: the patient's perspective. Eur Eat Disord Rev (2009) 0.79